Introduction {#s1}
============

Glucocorticoids (GCs) are central steroid hormones on endocrine stress response modulation and whole-body homeostasis in vertebrates. Downstream of the hypothalamic-pituitary-adrenal/interrenal (HPA/HPI) axis, regulated by a negative feedback loop, circulating CGs exert diverse actions by binding to glucocorticoid receptor (GR) placed on nearly every tissue in the body ([@B1]). In addition to well-known effects on glucose metabolism, immune system, reproduction, feeding, circadian rhythm, behavior, and cognition, GCs also regulate bone metabolism ([@B2]--[@B4]). Bone is a metabolically active tissue, shaped at an early stage of development and continuously remodeled throughout an animals\' lifetime. Bone remodeling regulated by systemic hormones, neural, and local factors, involves the coupled action of osteoclasts, osteoblasts, and osteocytes to replace old and damaged bone. This process preserves the mechanical strength and stiffness of the skeleton, maintains calcium-phosphorus homeostasis, acid/base balance, and releases growth factors as well as organic material embedded in bone ([@B5], [@B6]).

In vertebrates, the GCs action is complex. Despite stress hormones have long been considered as catabolic hormones, a dual metabolic effect has been found in the skeleton. Physiological levels of GCs are vital for normal skeletogenesis and bone mass accrual, which highlights an important anabolic role ([@B7]). However, an increase of GCs over the basal levels causes reduced bone growth, bone resorption and bone mineral loss as seen in Cushing\'s syndrome and GCs-induced osteoporosis (GIO), as well as other associated pathologies such as diabetes or sarcopenia ([@B8]--[@B10]). In humans, Cushing\'s syndrome (also named hypercortisolism) is characterized by an increased production of endogenous cortisol or GCs drugs resulting in detrimental effects on bone metabolism ([@B11]). Patients suffering from Cushing\'s disease exhibit a reduced bone mineral density, increased risk of fracture, suppression of osteoblastic differentiation and apoptosis of both osteoblasts and osteoclasts, among other symptoms ([@B12], [@B13]). Moreover, sustained exposure to exogenous GCs is also responsible for the so-called GIO as a consequence of long-term GC therapy ([@B14]). GIO has recently been investigated in fish, with zebrafish incubated in GCs showing reduced bone growth and impaired bone regeneration ([@B15]).

On the other hand, endogenous/exogenous GCs have been proposed to act as key regulators of osteocalcin expression in bone. Osteocalcin is a calcium-binding peptide synthesized by osteoblasts and osteocytes, involved in skeletal mineralization and, regulation of insulin production ([@B16]). Elevated GC levels suppress the osteoblast activity and inhibit the osteocalcin release in mammals ([@B17]). Therefore, GCs affecting bone formation also indirectly cause changes in whole-body energy metabolism ([@B8]). GCs are known to interact with parathyroid hormone (PTH) family members. Human PTH1 (PTH---the master regulator of bone mineral homeostasis) showed corticotropic activity in adrenocortical cell cultures ([@B18]). A feedback regulatory loop between cortisol and PTH3 (parathyroid hormone like hormone---PTHLH) has been described in vertebrates ([@B18]--[@B20]). In mammals, PTH3 participates in embryonic skeletal development ([@B21]), calcium mobilization during fetal-placental transport ([@B22]) and lactation ([@B23], [@B24]). While in fish, duplicated Pth3 factors are hormones involved in calcium uptake ([@B25], [@B26]), mineral release from scales ([@B27]), skeletogenesis and early mineralization ([@B28]).

To date, a substantial body of research has focused on the bone effects caused by a pathological increase of endogenous and exogenous GC levels, but few studies have reported the changes produced on bone metabolism due to the elevation of stress-induced GCs. As a natural mechanism, all organisms react to extrinsic and intrinsic stressors through the GC-mediated hormonal response to restore the equilibrium and preserve homeostasis. In this context, the skeleton is one of the target organs of the stress hormones and bone remodeling is an essential process that enables it to respond to changing conditions by modifying its structure and mineral composition. Stress responses are characterized by being variable across vertebrates and they are closely related to the type of stressor as well as the lineage-specific biology and ecology ([@B29], [@B30]). In this article, we review the action of stress-induce GCs on bone metabolism in vertebrates. Briefly, we define the current knowledge on the effect of endogenous GCs on bone under normal physiological conditions. Then, we describe how several stress factors affect bone mineral metabolism in two different vertebrate lineages: mammals (primarily human), which are endothermic terrestrial vertebrates, and fish, characterized as ectothermic aquatic vertebrates.

Endogenous GCs on bone development and homeostasis {#s2}
==================================================

Endogenous GC hormones regulate the expression of target genes through GR signaling within bone cells, affecting skeletal development and metabolism. The skeleton responsiveness to GCs and the subsequent activation or inhibition of the gene expression depends on the level of circulating stress hormones, the intracellular availability of active GCs and the GR activity ([@B1]). To date the study of GC actions on bone has focused on mammalian models. Initially, investigations were based on the global GR deletion which led to premature death in newborn mice by respiratory failure ([@B31]). This was followed by more advanced molecular approaches such as the bone cell-specific GR gene deletion or the osteoblasts-targeted transgenic expression of 11βHSD2 (enzyme that catalyzes the conversion of active to inactive GCs) to disrupt intracellular GC signaling. These studies contributed to better define the endogenous GCs effects under various physiological conditions. *In vivo* and *in vitro* studies carried out in cell cultures derived from 11βHSD2 overexpressing transgenic mice have reported the positive action of endogenous GCs during bone development ([@B32], [@B33]). GCs appeared to be essential for mice osteoblastogenesis as they control the lineage commitment of mesenchymal progenitor cells through osteoblasts by promoting the activation of Wnt signaling. In turn, Wnt proteins act on mesenchymal cells to increase the expression of β-catenin and RUNX2, the master regulator of osteoblast differentiation. Also, osteoblast GC activity disruption in 11βHSD2 transgenic mice revealed an important role for normal intramembranous ossification and proper cartilage removal during cranial development ([@B34], [@B35]). In addition to the GC actions during skeletogenesis in mammals, several studies have pointed out that endogenous GCs are also required to maintain the bone mass accrual and skeletal integrity across adulthood. Inactivation of osteoblast-specific GC signaling by using a GR knockout mouse model ([@B36]) or 11βHSD2 expressing transgenic mice ([@B37], [@B38]) resulted in a decrease of bone mineral density in adults, which was dependent on the skeletal site and sexual maturity ([@B37]). Moreover, a downregulation in the expression of osteoblasts differentiation markers (i.e*., Col1a1, Runx2*, bone sialoprotein, and osteocalcin) was found, suggesting failed osteoblastogenesis as well as mature osteoblast function ([@B36], [@B38]). Therefore, the major effects of endogenous GCs on bone development and homeostasis are probably due to its direct actions on osteoblasts. Nevertheless, due to a close and reciprocal interconnectivity between osteoblasts and osteoclasts for skeletal metabolism, *in vivo* studies involving endogenous GCs and osteoclasts are needed to specifically dissect the cellular actions on the skeleton.

Stress-induced glucocorticoid effects on bone mineral metabolism {#s3}
================================================================

GCs, including cortisol and/or corticosterone in mammals as well as cortisol in fish, are synthesized in the adrenal cortex of mammals, but in the interrenal tissue of the head kidneys in teleosts ([@B39]). In response to stress, the pituitary gland signals the adrenal gland/interrenal tissue to release GCs. These GCs are released into the blood and initiate numerous cellular events that promote changes in cells and tissues for adaptation to stressful stimuli ([@B40]) (Figure [1](#F1){ref-type="fig"}). In this context, it is important to distinguish between the degrees of stress that can ultimately affect bone homeostasis. Acute stress is sudden and transitory and it may trigger skeletal remodeling as an adaptive response, which confers survival advantage ([@B41]). After exposure to an acute stressor, GCs levels are rapidly increased in the blood before returning to basal levels via negative feedback mechanisms. However, chronic stress is a long-term stressor, sustained for a prolonged period of time or due to a frequently occurring stressor ([@B41]), through which GCs levels remain elevated which could lead to several pathological conditions including bone mineral loss ([@B2]). Stress-induced bone resorption can result in calcium and phosphate release and it can lead to irreversible damage of the bone architecture resulting in mechanical instability. In addition to intensity and duration of the stressor, the stress responses of vertebrates are highly variable depending on the type of stressor and the way it is perceived by each kind of species. Some key stress factors affecting bone mineral metabolism in mammals and fish are described in this section including mineral demands, environmental change, starvation, physical exercise, psychological stress, and aging (Figure [1](#F1){ref-type="fig"}).

![Stress-induced cortisol affecting bone mineral metabolism in human and fish. Stressors including mineral demands, environmental change, starvation, physical exercise, psychological stress, or aging trigger the hypothalamic-pituitary-adrenal/interrenal (HPA/HPI) axis activation in human and fish, respectively, leading acute and chronic effects on the skeleton.](fendo-09-00526-g0001){#F1}

Mineral demands
---------------

The skeleton is the major mineral storage organ in the vertebrate body and takes part in the regulation of calcium-phosphate metabolism. Thus, skeleton provides calcium and phosphate through bone resorption to compensate the inadequate availability of minerals in the environment and/or in the diet to maintain essential ionic levels in blood ([@B5], [@B42]). Unlike terrestrial vertebrates, fish can absorb minerals from surrounding water across the skin, oral and branchial epithelium, so stressors related to water and ion homeostasis have a greater physiological impact ([@B29]). In teleosts, the role of cortisol on osmoregulation has widely been reported ([@B43]) but, the contribution of cortisol on the ionic balance related to bone mineral homeostasis has received less attention ([@B44]). Previous studies showed that fish exposed to low calcium water levels give rise to high plasma cortisol levels in rainbow trout ([@B45], [@B46]), and stimulates the gene expression of steroid 11β-hydroxylase (final-step enzyme for cortisol synthesis) as well as glucocorticoid receptor (*gr*) in zebrafish ([@B47]). Moreover, cortisol treatment was shown to induce *in vitro* calcium transport in cultured rainbow trout gill epithelium, which supports its hypercalcemic role ([@B48]). Also, tilapia exposed to exogenous cortisol showed an increase in calcium uptake and upregulation of epithelial Ca^2+^ channel (*ecac*) gene expression ([@B49]). It would therefore appear that teleost fish regulate the calcium uptake to cope with a fluctuating water environment which is closely related to bone homeostasis. Alternatively, studies with juvenile seabream showed a plasma cortisol increase after prolonged exposure to low calcium availability in the water and/or diet, which resulted in reduced whole-body calcium and phosphorus contents ([@B50]). In the European eel, chronic cortisol treatment induced mineral loss in vertebral bone through osteoclastic resorption and osteocytic osteolysis ([@B51]). Interestingly, it has been suggested that cortisol mobilization of bone mineral stores in eel may be evidence of an ancestral stress-induced physiological process ([@B51]) related to the effects of stress events in mammals (e.g., starvation, physical exercise, psychological stress, or aging).

An interaction between hypercalcemic PTH factors regulating bone mineral metabolism and cortisol has been reported in mammals and fish (Table [1](#T1){ref-type="table"}). Both PTH1 and PTH3, stimulated cortisol release from human adrenocortical cells *in vitro* ([@B18]), although only the gene encoding PTH3 appears to be regulated by GCs ([@B19]). Similarly, piscine Pth3 showed *in vitro* corticotropic activity on isolated sea bream interrenal glands ([@B20]). In turn, sustained cortisol levels in sea bream as a consequence of a 24h confinement stressor or *in vivo* cortisol intraperitoneal injection resulted in a decrease in plasma Pth3 levels ([@B52]). Similar to cortisol, sea bream PTH3 is produced in interrenal tissue in fish ([@B20], [@B53]) and therefore an autocrine and/or paracrine regulatory mechanism between these two hormones was proposed ([@B52]). However the underlying molecular regulation remains unclear and it is possible that Pth3 acts indirectly at other levels of the HPI axis. Contradictory results regarding the cortisol-Pth3 reciprocal regulation were found in sea bream exposed to limited calcium availability in the long-term. Fish either under low calcium water along with a calcium-sufficient diet or under regular calcium water but calcium-deficient diet showed elevated plasma cortisol and Pth3 levels ([@B50]).

###### 

Summary of some of the reported studies including PTH-cortisol regulatory interactions in mammals and fish.

  **Hormone**   **Species**       **Action**                 **Tissue**                     **References**
  ------------- ----------------- -------------------------- ------------------------------ ----------------
  PTH1          *Homo sapiens*    Cortisol release           Adrenocortical cells culture   [@B18]
  PTH3          *Homo sapiens*    Cortisol release           Adrenocortical cells culture   [@B18]
  Cortisol      *Mus musculus*    PTH3 expression increase   Kidney                         [@B19]
  Pth3          *Sparus aurata*   Cortisol release           Isolated interrenal glands     [@B20]
  Cortisol      *Sparus aurata*   Pth3 expression decrease   Blood                          [@B52]

Environmental change
--------------------

Environmental stressors like temperature fluctuations are a critical feature of homeostasis in an organism. This is of particular relevance for ectothermic animals such as fish, where temperature directly influences their normal physiology. Sea bream exposed to water temperatures below 13°C develop winter syndrome, which is characterized by a multi-organ dysfunction together with a high but transient rise of plasma cortisol levels triggering a stress response ([@B54], [@B55]). A recent study in sea bream has revealed the impact of cold challenge, which increased the cortisol production and affected bone homeostasis in juveniles ([@B55]). Thus, fish exposed to low temperature during early development showed altered enzymatic activities of alkaline phosphatase (ALP) and tartrate-resistant acid phosphatase (TRAP) as well as calcium content changes on the vertebral bone ([@B55]). Interestingly, temperature is also a modulator of the expression of PTH family members. Zebrafish embryos exposed to cold (18°C) stress showed up-regulated mRNA levels of *pth1a, pth1b, pth3a, pth3b*, and *pth1rb*, while those exposed to a hot (38°C) stress down-regulated mRNA levels of these genes ([@B56]). Therefore, it is likely that such changes may impact mineral balance, altering bone development in embryos. However, to our knowledge, there are no studies showing a correlation between temperature-driven levels of cortisol and PTH family members affecting bone metabolism.

Starvation
----------

A common stressor in the wild is food deprivation, which can be caused by adverse weather, decline in prey availability, increased predator pressure and migration or hibernation, among others. Under these conditions, it is well know that GCs are released into the blood to promote the mobilization and utilization of energy reserves and mineral stores in vertebrates ([@B57]). Regarding migratory teleost fish like salmonids, spawning migration is a very challenging situation since they undergo not only fasting but also exhausting exercise, changes in osmoregulation and sexual maturation ([@B58]). Thus, migratory salmonids, essentially as adults returning to spawning grounds, experience a strong activation of the neuroendocrine axis resulting in elevated plasma corticosteroid levels ([@B59]) as well as marked resorption of the skeleton. In particular, the anadromous Atlantic salmon was reported to experience a dramatic skeletal transformation caused by a decrease in the bone mineral content, halastic demineralization, osteoclastic resorption, and reduced vertebral bone mass ([@B60]--[@B62]). Nevertheless, a recent study in the migratory European eel showed that sexually mature fish via cortisol injection exhibited severe bone loss in the vertebrae and skull, while plasma cortisol levels were reduced ([@B63]). Therefore, a cortisol-independent bone resorption mechanism has been suggested in migratory eels ([@B63]). Some mammalian species also experience a situation of nutritional deprivation during hibernation similar to that observed in migratory fish. Small mammals such as little brown bats and hamsters lose a significant bone mineral volume during hibernation ([@B64], [@B65]), but only high plasma cortisol levels have been detected in bats ([@B66]). On the other hand, cortisol is increased in hibernating bears, however they maintain a typically balanced bone turnover which prevents bone reabsorption excess and osteoporosis ([@B67], [@B68]). Furthermore, fasting studies in humans have shown an increase in blood cortisol concentration ([@B69]) accompanied by a decrease of PTH secretion, which is suggested to have some positive effect on the bone health ([@B70]).

Physical exercise
-----------------

Physical exercise represents a stressful experience for all organisms. In mammals, physical activity promotes direct effects on bone metabolism via mechanical forces (i.e., weight-bearing activities), but also indirectly through hormonal factors ([@B71]). Hence, exercise causes HPA axis activation and the subsequent release of GCs into the blood. Although physical exercise has been reported to prevent bone mineral loss and to sustain bone health, long-term intense exercise is reported to cause hypercortisolism, which can result in osteopenia and osteoporosis ([@B71]). Some studies have showed that over-trained runners exhibit elevated ACTH and cortisol basal concentrations compared with moderately trained runners and sedentary subjects ([@B72]). However, the HPA axis activation was attenuated in over-trained runners after exposure to an acute exercise, suggesting a certain adaptation to physical exercise ([@B72]). Other investigations have reported that highly trained male master cyclists ([@B73]) and competitive male cyclists show low bone mineral density in the hip and spine, however there is no clear association between bone mineral content and excess of GC secretion ([@B74]). Exercised fish show improved growth and increased bone remodeling ([@B75]). However, the most extreme examples of possible interactions between GCs and bone metabolism during exercise may arise from migratory fish such as the salmonids or eels (see also under *Aging*). In experiments that were aimed to simulate to some extent the skeletal-loss consequences of a 5,000 km migration to reproductive grounds ([@B51], [@B63]) demonstrated that cortisol induced a significant bone demineralization of Europen eel vertebrae, with significant decreases of the mineral ratio and the degree of mineralization of vertebral sections. Using histology and image analysis of ultrathin microradiographs they showed the induction by cortisol of different mechanisms of bone resorption, including periosteocytic osteolysis and osteoclastic resorption. These effects were further enhanced by sex steroids. Specificity of cortisol action was investigated by comparison with the effects of sex steroids, namely estradiol, related to the stimulated synthesis of vitellogenin (Vg), an oviparous specific phospho-calcio-lipoprotein. Such effects of estradiol have been profusely shown in salmonids ([@B76]). However, in above study, the ready-to-migrate eels were not actually exercised but simply injected with steroids and thus the evidence for the effects of exercise-related GCs.

Psychological stress
--------------------

It has recently been demonstrated that psychological stress affects bone metabolism in humans and some animal models ([@B77]--[@B81]). Although the psychological stress response is complex, as it depends on individual interpretation, it has been suggested that long-term psychological stress produces altered HPA axis activity and as a consequence, GC release affecting bone health ([@B77]). In rats, chronic psychological stress by anxiety neurosis results in the loss of mandibular bone matrix ([@B78]). Post-traumatic stress disorder, which is related to altered serum GCs, caused a decrease of bone mineral density and bone mineral contents in young mice ([@B79]). In humans, the relationship between depression and bone mineral density has also been associated with stress-induced cortisol effects. Post-menopausal women with depression showed loss of bone mineral density in the lumbar spine and femur compared to non-depressed subjects, as well as a higher cortisol production after an acute stress experience ([@B80]). Furthermore, pre-menopausal women suffering from chronic depression presented a negative correlation between cortisol levels and bone mineral density, as well as low osteocalcin levels suggesting a decrease in bone formation ([@B81]). Recently there has been increased attention to the impact of social or psychological stress in fish, in parallel with the recognition of an increased degree of sentience and multiple individual coping styles, to which some may even refer as "personalities" in fish. The way fish exhibiting those different coping styles address stressful events determines to some extent their rank, access to food, energy expenditure, growth rates and cortisol response levels ([@B82], [@B83]). However, to date, there is no information on the impact of psychological stress and induced GC levels on fish bone.

Aging
-----

Aging is an imbalance between damage and repair that makes organisms undergo an increasing vulnerability to challenges during the post-maturational life, decreasing their ability to survive ([@B84]). Along these lines, aging disturbs the homeostatic system but perhaps it should not be considered as a stressor since it does not elicit *per se* a physiological stress response. However, aging is closely related to responsivity to stress and it seems to produce similar effects to those seen in the chronic stress response. In mammals, aging causes greater HPA axis activation and thereby an excess production of GCs that negatively affect bone metabolism ([@B7]). It has been proposed that HPA axis hyperactivity could be due to a decrease in the number of GC receptors in the brain, which in turn affects the negative feedback regulation, but can also be the result of repeated stress events ([@B7]). An age-related increase of corticosterone as well as upregulation of 11βHSD1 (enzyme that activates GCs) expression in bone, which led to reduced bone vasculature and skeletal fragility in mice ([@B85]). Studies in humans have provided evidence that elevated cortisol levels affect bone mineral density. Thus, elderly men and women with a high level of evening salivary cortisol had a reduced bone mineral density in the lumbar spine ([@B86]). Also, high plasma cortisol levels in older women contributed to bone loss in the femoral neck ([@B87]). Additionally, a positive correlation between cortisol concentration and bone loss rate was found in the lumbar spine in elderly men ([@B88]). Fish grow continuously throughout their lives and usually their skeleton maintains its integrity with aging. A few exceptions can be found in semelparous species, such as many salmonids and eels ([@B51], [@B63], [@B76]) in which sexual maturation, reproduction and related skeletal remodeling coincide with the end of life. Both GC and sex steroids increase along the migratory route and peak levels coincide with important organ and skeletal remodeling. In pink salmon specifically, cortisol levels rise over 20-fold in both males and females ([@B89]) being thus likely that GCs may have important effects over bone metabolism. Despite the fact that most fish do not appear to undergo important skeletal changes as they age, the use of fish as models for probing into aging-related health conditions with impacts on bone mineral metabolism in human offers ample possibilities, since they can be treated and selected to simulate such conditions, including those directly or indirectly related to disturbances in circulating GCs ([@B90]--[@B93]).

Conclusion {#s4}
==========

In response to a variety of stressful situations and/or stimuli that challenge the internal equilibrium in vertebrates, bone appears to be a target organ for stress-induced GCs produced by HPA/HPI axis activation. In mammals, as in fish, elevated GC levels sustained over time result in bone resorption, which alters the mineral balance and damages the bone structure. Although this evidence suggests that stress-induced GCs may act in a similar fashion to that of therapeutic GCs, there is a gap in the knowledge about the cellular and molecular mechanisms involving the stress response, cortisol and bone mineral metabolism in vertebrates. Studies utilizing mammalian models based on the pathological increase of endogenous GCs and pharmacological GCs reported that the bone effect of these hormones could be due to its direct action on osteoblasts ([@B34], [@B35]). However, the actions of stress-induced GCs on bone cells as well as the interactions between GCs and other factors regulating bone homeostasis are currently unknown.

Author contributions {#s5}
====================

PS-B, PG, and JR wrote and revised the manuscript.

Conflict of interest statement
------------------------------

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

**Funding.** This work was funded by the Spanish Economy and Competitiveness Ministry projects AGL2014-52473R and AGL2017-89648P to JR. PS-B was supported by AGL2014-52473R and AGL2017-89648P project contracts. PG acknowledges the Portuguese Foundation for Science and Technology (project grant PTDC/BIA-ANM/4225/2012).

[^1]: Edited by: Lluis Tort, Autonomous University of Barcelona, Spain

[^2]: Reviewed by: Takashi Yada, Japan Fisheries Research and Education Agency (FRA), Japan; Takashi Yazawa, Asahikawa Medical University, Japan

[^3]: This article was submitted to Experimental Endocrinology, a section of the journal Frontiers in Endocrinology
